Table:
begin	end	state
1	29	cytoplasmic
30	49	transmembrane
50	57	non-cytoplasmic
58	80	transmembrane
81	91	cytoplasmic
92	112	transmembrane
113	117	non-cytoplasmic
118	138	transmembrane
139	156	cytoplasmic
157	179	transmembrane
180	190	non-cytoplasmic
191	210	transmembrane
211	238	cytoplasmic
239	259	transmembrane
260	277	non-cytoplasmic
278	297	transmembrane
298	308	cytoplasmic
309	327	transmembrane
328	333	non-cytoplasmic
334	357	transmembrane
358	367	cytoplasmic
368	390	transmembrane
391	401	non-cytoplasmic
402	420	transmembrane
421	431	cytoplasmic

Input:
>AO353_17220 FitnessBrowser__pseudo3_N2E3:AO353_17220
MTTITSLYTAEERGKRIFAIVGASSGNLVEWFDFYVYAFCAIYFAPAFFPSDNPTVQLVN
TAGVFAAGFLMRPIGGWLFGRVADKHGRKNSMMISVLMMCAGSLLIACLPTYKDIGVWAP
LLLLVARLIQGVSVGGEYGTTATYMSEVALKGQRGFFASFQYVTLIGGQLLAVSLVVILQ
QFLTEDDLRAWGWRIPFVVGAAAALISLFLRRSLKETTSKEMRENKDAGSMAALFRNNTA
AFITVLGFTAGGSLIFYTFTTYMQKYLVNTAGMPAKTASYIMTGALFLYMCMQPLFGTLA
DKIGRRNSMLWFGALGTLFTVPILLTLKSVTNPFLAFGLITVALAIVSFYTSISGLVKAE
MFPPQVRALGVGLAYAVANAIFGGSAEYVALSLKSVGIENSFYWYVTAMMAIAFLFSLRL
PRQAAYLENEL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server